- Raised $47M Series A led by Khosla Ventures, Aug 2025
- Raised $5.3M Pre-Seed round led by TechAviv, Apr 2024
- Raised $4.8M Pre-Seed Extension led by Paul Harris, Sep 2024
About
Cellular Intelligence (formerly Somite.ai) is an AI-native TechBio and clinical-stage company building a universal foundation model of cell signaling to understand, predict, and ultimately control cellular behavior, transforming biology from trial-and-error into an engineering discipline. The company takes a full-stack approach, generating perturbation data at over 1,000x the efficiency of conventional methods, capturing millions of time-resolved treatment combinations per experiment and training large-scale models that generalize across contexts to enable rational protocol design for regenerative medicine, context-specific drug effect prediction and systematic disease modeling. Their proprietary capsule technology generates dynamic cellular data at over 1,000x higher efficiency than existing methods. The company has acquired global rights to STEM-PD, a clinical-stage allogeneic cell therapy program for Parkinson's disease with FDA Fast Track Designation, from Novo Nordisk. This program serves as both a therapy the company is advancing for patients and a proving ground for its technology.
Funding history · 3 rounds · $57.1M total
Headcount over time
Offices
Show all offices (1 more)
- Boston, United States
Q&A
- What is Somite.ai's primary focus?
- Somite.ai is a TechBio company that leverages foundation models and proprietary AI to accelerate human cell therapy development, aiming to revolutionize the production of human cell types for various diseases.
- When was Somite.ai founded?
- Somite.ai was founded in October 2023.
- How much funding has Somite.ai raised to date?
- Somite.ai has raised a total of $60,000,000 USD.
- Which investors participated in Somite.ai's Series A funding round?
- In May 2025, Somite.ai secured a Series A round of $47,000,000, led by Khosla Ventures.
- What was the amount of Somite.ai's initial Pre-Seed funding round?
- In April 2024, Somite.ai raised $5,300,000 in a Pre-Seed round, with TechAviv as a lead investor.
- What is the employee count for Somite.ai?
- Somite.ai has an employee count in the 11-50 range.
- Where is Somite.ai headquartered?
- Somite.ai is headquartered in Tel Aviv, Israel, with an additional office in Boston, United States.
- What is the name of Somite.ai's platform?
- Somite.ai's platform is called DeltaStem, which is designed to revolutionize the production of human cells.
Team · 11
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | cellularintelligence.com |
|---|---|
| linkedin.com/company/98835010 |
Identifiers & details
| Legal name | Somite Therapeutics Inc. |
|---|---|
| Founded | 2023-10 |
| Employees (exact) | 42 |
| Offices | Boston |
Radar intelligence
Web history (Wayback)
| Domain | cellularintelligence.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|